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suggestive of a vector mite bite, and a positive serodiagnostic
for O. tsutsugamushi without other rickettsial serologies. The
reversal of an evolution apparently headed to a fatal outcome
under a treatment active on O. tsutsugamushi provides a strong
additional presumption. Antibody titers may seem low, but
since serodiagnostics were performed tardily, these titers may
have already been decreasing. Another explanation would be
an impaired immune response that could explain the disease
severity and the persistent efficacy of antibiotic therapy at a
late stage.
Pneumonia is a well-documented complication of rickettsial
diseases, but ARDS is rare (6 cases) [3, –7]. Our observation
seems to confirm that western practitioners should suspect
scrub typhus in travelers returning from Southeast Asia with
respiratory symptoms (if travel conditions make vector bites
possible), because of the potentially severe course.
The use of tetracyclines in populations at risk of scrub typhus
has dramatically reduced the associated mortality rate and
probably explains the decrease in severe complications [2, 8].
Other active antibiotics include chloramphenicol [2] and cip-
rofloxacin [9]. Data on the clinical efficacy of fluoroquinolones
are scarce. Ofloxacin was prescribed to our patient to broaden
the spectrum of antibiotic therapy. When the diagnosis of scrub
typhus was suspected, retrospective analysis of the clinical
course strongly suggested a link between improvement and of-
loxacin administration. The decision not to add a tetracycline
to the therapeutic regimen was thus taken, and the patient’s
condition continued to improve. Therefore, ofloxacin activity
seems likely, all the more so because a spontaneously favorable
outcome, impossible to rule out, is made unlikely but the se-
verity of the MOF. The description of doxycycline and chlo-
ramphenicol-resistant strains of O. tsutsugamushi in northern
Thailand [10] would make the efficacy of fluoroquinolones in
scrub typhus an interesting therapeutic alternative. Such effi-
cacy is suggested by the case that we describe here, although
it is clear that evidence beyond a single case is needed.
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Acute Community-Acquired Diarrhea Requiring
Hospital Admission in Swiss Children
In order to ascertain the prevalence of agents that cause
childhood diarrheal illness, stool specimens of 312 con-
secutive children with community-acquired diarrhea re-
quiring admission were evaluated. Pathogens were de-
tected in 166 (53%) of the 312 children (>2 pathogens in
28 children): Rotavirus ( ), Salmonella spp. (n p 75 n p
), Campylobacter spp. ( ), Shigella spp. ( ),37 n p 24 n p 5
Giardia spp. ( ), Yersinia spp. ( ), Aeromonas spp.n p 4 n p 2
( ), Cryptosporidium ( ), enteropathogenic Es-n p 15 n p 15
cherichia coli ( ), enterotoxigenic E. coli ( ), andn p 13 n p 7
enterohemorrhagic E. coli ( ). In conclusion, acuten p 5
childhood diarrheal illness pathogens, such as Aeromonas,
Cryptosporidium, and diarrheagenic E. coli, account for a
large proportion of patients with a microbiologically pos-
itive stool specimen.
Acute childhood diarrheal illness represents a major cause
of morbidity even in temperate, industrialized areas. Infectious
agents long been known to cause acute diarrheal illness in such
climates areas include Salmonella spp., Shigella spp., Campy-
lobacter spp., Yersinia spp., Rotavirus and Giardia lamblia [1].
Recent advances in our understanding of enteric pathogens and
improved diagnostic techniques have identified new agents of
diarrhea, such as Cryptosporidium parvum, diarrheagenic Es-
cherichia coli, or Aeromonas spp. [1].
Because the relative frequency of the different etiologic agents
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Table 1. Age, symptoms, and signs in 166 children with diarrhea, according to pathogens identified in stool specimens.
Pathogen n Age, y
Body temperature,
7C Vomiting
History of
stay in
hot
climate
History of
diarrheal
contact
Bloody
stool
Volume depletion
Mild Moderate Severe
Rotavirus 75 1.4 (0.9–2.0) 39.2 (37.9–39.2)a 93 4 27 5 76 21 3
Salmonella spp. 37 2.8 (1.4–4.3)b 39.9 (39.1–40.3)a 89 16 49 51c 57 35 8
Campylobacter spp. 24 2.7 (0.69–7.9)b 39.1 (37.8–39.3)a 79 29 21 17 71 25 4
Shigella spp. 5 4.4 (3.1–6.3)b 39.0 (38.1–39.3)a 80 60d 20 80c 60 40 0
Aeromonas spp. 15 1.2 (0.6–2.0) 38.0 (37.0–39.0) 60 27 33 20 73 27 0
Cryptosporidium spp. 15 1.7 (1.2–2.2) 39.1 (38.3–39.3)a 80 20 40 7 67 33 0
Enteropathogenic E. coli 13 1.4 (0.5–3.0) 37.6 (37.4–38.4) 69 23 23 8 46e 38 16
Enterotoxigenic E. coli 7 0.6 (0.4–1.4) 37.9 (37.6–38.5) 86 57d 57 0 29e 57 14
Enterohemorrhagic E. coli f 5 0.7 (0.4–1.5) 38.2 (37.7–38.9) 80 20 40 100c 20e 40 40
NOTE. Data are either median (interquartile range) or relative frequency. Data are percentages, unless otherwise indicated. Only pathogens isolated in >5
children are considered. Two or more pathogens were found in 28 of the 166 patients (this fact accounts for apparent mathematical discrepancies). E. coli, Escherichia
coli.
a vs. Aeromonas spp. or diarrheagenic E. coli.P ! .01
b vs. Rotavirus, Aeromonas spp., Cryptosporidium spp., and diarrheagenic E. coli.P ! .01
c vs. Rotavirus, Campylobacter spp., Aeromonas spp., Cryptosporidium spp., and enteropathogenic or enterotoxigenic E. coli.P ! .02
d vs. Rotavirus, Salmonella, Campylobacter, Aeromonas, Cryptosporidium, and enteropathogenic or enterohemorrhagic E. coli.P ! .05
e vs. Rotavirus, Salmonella spp., Campylobacter spp., Shigella spp., Aeromonas spp., and Cryptosporidium spp.P ! .05
f None of the isolates belonged to the serogroup 0157.
linked with acute infectious diarrhea greatly varies according
to the geographic and socioeconomic settings [1], we undertook
a study of the etiology and clinical features of community ac-
quired diarrheal illness in children admitted at the Department
of Pediatrics, University of Bern, Switzerland.
The Department of Pediatrics, University of Bern, Switzerland,
is a 60-bed pediatric teaching hospital that serves as tertiary
referral center. The catchment area has a population of approx-
imately 400,000 people of various social and ethnic backgrounds.
All patients aged between 5 weeks and 15 years who required
hospital admission because of an acute, community-acquired
diarrheal illness were eligible. Acute diarrhea was defined as an
abnormal increase in stool liquidity and frequency of <9 days
of duration. Children treated with antibiotics or drugs known
to cause diarrhea in the preceding 2 weeks and immunocom-
promised patients were excluded. Three hundred twelve con-
secutive patients fulfilled these criteria and were prospectively
evaluated from January 1990 through December 1994. They
were 175 boys and 137 girls, ranging in age from 1.5 months
to 13 years (median, 1.5 years).
The history before admission and the initial physical ex-
amination were used to ascertain a recent (!10 days) stay in a
hot climate, poorly industrialized country, a recent diarrheal
contact (at home or at a nursery), the quality of stools (watery
or grossly bloody, by examination), the rectal body temperature
(on admission), and the degree [2] of extracellular volume de-
pletion (assumed to be moderate in patients with 2 and severe
in those with >3 of the following signs: altered skin elasticity,
sunken eyes, dry mucous membranes, absent tears, or delayed
capillary refill). A complete WBC count in peripheral blood
was performed in all patients. Leukocytosis was defined as a
WBC count higher than the age dependent upper reference
value [3]: children aged <24 months, cells/L; children917.5 3 10
aged 25 months to 5 years, cells/L; and children aged915.5 3 10
>6 years, cells/L. The leukocytes were differentiated913.5 3 10
by microscopy, and a segmented neutrophil granulocyte was
defined by at least 1 indentation of the nucleus to less than
one-third of the maximal nuclear diameter. A shift to the left
was defined as nonsegmented polymorphonuclear cells 110%
of the total WBC count [3].
In the 312 patients, a stool specimen was collected within 24
h of admission and processed for Rotavirus, Salmonella spp.,
Campylobacter spp., Shigella spp., Yersinia spp., Giardia lam-
blia, and C. parvum at the Institute for Clinical Microbiology,
University of Bern, Switzerland. Standard laboratory tech-
niques were used for Salmonella spp., Campylobacter spp., Shi-
gella spp., and Yersinia spp. [4]. G. lamblia and C. parvum were
detected in a fresh stool specimen fixed by use of the sodium
acetate-acetic acid formalin medium. The specimen was con-
centrated, and a wet mount was examined for the presence of
cysts and trophozoites of G. lamblia or oocysts of C. parvum,
identified by staining the specimen by use of auramine-carbol-
fuchsin and visualized by fluorescent microscopy [5].
Aeromonas spp., enteropathogenic E. coli, enterotoxigenic E.
coli, and enterohemorrhagic E. coli were isolated at the Ref-
erence Laboratory for Foodborne Diseases, University of Bern.
Briefly, stool specimens were streaked onto cefsulodin-irgasan-
novobiocin agar for isolation of Aeromonas spp. and Mac-
Conkey agar for isolation of E. coli [6]. Suspect colonies on
cefsulodin-irgasan-novobiocin agar were subcultured onto Sim-
mons citrate medium and blood agar, and oxidase- and citrate-
negative colonies were identified by use of standard procedures
[7]. For identification of diarrheagenic E. coli, 6 representative
colonies were picked from the MacConkey agar, identified by
conventional procedures, and used in a colony-blot hybridi-
zation assay. Probes and conditions used for the detection of
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Table 2. Peripheral blood total WBC count in 166 children with diarrhea, according
to pathogens identified in stool specimens.
Pathogen identified n
Total WBC
count, 3109 cells/L
Leukocytosis,
% of patients
Nonsegmented PMN
increased, %
Rotavirus 75 13.2 (9.6–17.3) 24 40
Salmonella spp. 37 11.0 (8.4–15.9) 24 70a
Campylobacter spp. 24 11.5 (8.0–15.4) 25 54a
Shigella spp. 5 14.1 (12.3–18.1) 40 80a
Aeromonas spp. 15 9.6 (7.0–13.1) 13 27
Cryptosporidium spp. 15 14.9 (10.2–19.6) 47 33
Enteropathogenic E. coli 13 17.6 (13.8–19.2) 62b 15
Enterotoxigenic E. coli 7 18.3 (15.9–20.0) 57b 14
Enterohemorrhagic E. coli 5 18.9 (17.0–22.5) 80b 80a
NOTE. Data are either median (interquartile range) or relative frequency. Only pathogens isolated
in >5 children are considered. Two or more pathogens were found in 28 of the 166 patients (this fact
accounts for apparent mathematical discrepancies). Leukocytosis was defined according to the lit-
erature [3] and “shift to the left” nonsegmented PMN 110% of the total WBC count [3]. E. coli,
Escherichia coli; PMN, polymorphonuclear cells.
a vs. Rotavirus, Aeromonas species, Cryptosporidium species, enteropathogenic E. coli, andP ! .01
enterotoxigenic E. coli.
b vs. Rotavirus, Salmonella species, Campylobacter species, Shigella species, AeromonasP ! .01
species, and Cryptosporidium species.
Figure 1. Monthly distribution of admission for acute diarrheal
illness in 312 consecutive patients from January 1990 through Decem-
ber 1994. Patients with (m) and those without (M) isolated pathogens
are distinguished.
enterotoxigenic E. coli (heat stable and heat labile enterotoxins),
enteropathogenic E. coli (probes for the virulence plasmid as-
sociated EAF and chromosomal eaeA genes), and enterohe-
morrhagic E. coli (probes for Shigatoxin and the virulence gene
eaeA) have been described elsewhere [8–10]. Enteroinvasive E.
coli were detected by use of a digoxigenin-labeled ipaH probe
[11] produced by PCR using the primer pair 5′-CTGGCTGAT-
GCCGTGACAGC-3′ (forward), 5′-CGGTCAGCCACCCTC-
TGAGA-3′ (reverse), and genomic deoxyribonucleic acid of
Shigella flexneri NZ 194-95 as a template.
Isolates of enterohemorrhagic E. coli were agglutinated in
antisera against O157 and H7 antigens of E. coli in commer-
cially available sera including passage of the strains in semisolid
motility medium to enhance expression of flagellar antigens.
The presence of O157 antigens was also assessed by aggluti-
nation in a latex reagent, rapid sorbitol fermentation was as-
sessed on Sorbitol-MacConkey plates (Oxoid, Basingstoke,
UK), and production of glucuronidase was measured with a
fluorogenic substrate (Bactident; Merck, Germany).
The results are given as relative frequency or as median and
interquartile range. The x2 test (with the Yates correction) and
the 2-tailed Kruskal-Wallis test (with the Bonferroni adjust-
ment) were used for analysis [12]. Differences that had a prob-
ability 1.05 by the appropriate null hypothesis were considered
insignificant.
Pathogens were detected in stool samples from 166 of the
312 patients with acute diarrheal illness included in the study
(>2 pathogens were found concomitantly in 28 children): Ro-
tavirus, Salmonella spp., Shigella spp., Aeromonas spp., Cryp-
tosporidium spp., diarrheagenic E. coli, and Campylobacter spp.
were isolated each in at least 5 children (table 1). G. lamblia
( ; 1.3%) and Yersinia spp. ( ; 0.6%) were detected inn p 4 n p 2
a small minority of patients. No enteroinvasive E. coli were
detected.
The salient characteristics of patient history and clinical pre-
sentation are summarized in tables 1 and 2. Children infected
with Salmonella spp., Campylobacter spp., or Shigella spp. were
significantly older than were children infected with Rotavirus,
Cryptosporidium spp., Aeromonas spp., or diarrheagenic E. coli.
A history of travel abroad was given by roughly two-thirds of
patients infected with Shigella and enterotoxigenic E. coli,
whereas on average 85% of the other pathogens were domesti-
cally acquired. Although the body temperature was significantly
higher in patients with acute diarrheal illness caused by Rota-
virus, Salmonella spp., Campylobacter spp., or C. parvum, there
was a considerable overlap with findings in patients infected with
other pathogens, and clinical symptoms did not permit a clear
distinction of diarrheal syndromes.
This was also true for the results of the total WBC count.
Peripheral blood leukocytosis was noted in the majority of the
patients with acute diarrheal illness caused by diarrheagenic E.
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coli. A shift to the left was noted in the majority of the children
with diarrhea caused by Salmonella spp., Campylobacter spp.,
Shigella spp., or enterohemorrhagic E. coli. However, grossly
bloody diarrhea was present in all patients infected with en-
terohemorrhagic E. coli (80% of those with shigellosis and 51%
of those with salmonellosis). The extracellular volume depletion
was slightly more pronounced (moderate or severe) in patients
with acute diarrheal illness caused by diarrheagenic E. coli. An
8-month-old girl with bloody diarrhea caused by enterohe-
morrhagic E. coli developed hemolytic uremic syndrome. Chil-
dren with acute diarrheal illness were admitted throughout the
year (figure 1). However, admissions tended to be more frequent
during the warmer months. No etiology-specific seasonality was
noted.
The results of the present study demonstrate that in this
region pathogens, such as C. parvum, enteropathogenic E. coli,
enterotoxigenic E. coli, enterohemorrhagic E. coli, or Aero-
monas spp., play an important role in the etiology of inpatients
with acute diarrheal illness, as indicated by the fact that these
pathogens were isolated in stool specimens from 18% of the
pediatric patients with acute community acquired diarrheal ill-
ness that required admission.
The well-established pathogens Rotavirus, Salmonella spp.,
Campylobacter spp., Shigella spp., and Yersinia spp. [1] still
represent a major cause of acute diarrheal illness in Swiss chil-
dren. Compared with a survey performed at this institution
from 1981 through 1984 [4], the relative frequency of acute
diarrheal illness caused by Rotavirus tended to decrease (from
42% to 24%). In contrast, there was an increase in diarrhea
caused by Salmonella spp. (from 9% to 12%) and Campylo-
bacter spp. (from 3% to 8%).
The most frequent so-called emerging pathogen in this study
was C. parvum. This protozoan was long known to cause di-
arrheal diseases in the immunocompromised but is now a rec-
ognized agent of acute diarrhea in all groups of patients [12].
Cryptosporidium also causes an important number of sporadic
cases of diarrhea worldwide, with widely differing prevalence
rates among regions [12]. The identification of Cryptosporidium
is important for prognostic, epidemiological, and therapeutic
reasons, since the symptoms tend to persist or recur for pro-
longed periods [13]. The organism is easily transmitted from
person to person, and no uniformly efficacious therapy is avail-
able [12].
In this study, Aeromonas spp. was detected in 4.8% of the
stool specimens. This frequency is similar to that reported from
other industrialized countries (2.2%–10%). Although the epi-
demiological association between diarrheal disease and the
presence of Aeromonas spp. in stools has been firmly established
in many studies worldwide, there is still some controversy about
its role as a pathogen [7]. A common clinical picture caused by
isolates of Aeromonas spp. emerges from the literature: acute-
onset watery diarrhea in infants and toddlers with slightly el-
evated body temperature. Vomiting is less common than in
diarrhea caused by other pathogens, and the total WBC count
rarely shows a leukocytosis or a shift to the left [14].
The most significant advances in our understanding of enteric
pathogens have been made in the study of strains of E. coli
that cause diarrhea [15]. Enteropathogenic, enterotoxigenic,
and enterohemorrhagic [15] E. coli accounted together for 8.0%
of the positive stool specimens in the present study. Thus, as a
group, these pathogens were as prevalent as Campylobacter
spp., being the third most frequent pathogens isolated. Among
the diarrheagenic E. coli, enteropathogenic E. coli was the most
common type detected. Although often considered a pathogen
in developing countries, 77% of the cases observed were do-
mestically acquired, which concurs with recent observations in
the United States [16]. The second most prevalent category of
diarrheagenic E. coli were enterotoxigenic E. coli. They are the
main agent of travelers’ diarrhea, and, consistent with this, all
but one of the patients shedding this organism had recently
traveled to areas where this pathogen is prevalent [15].
The most important new pathogen in terms of the severity
of associated illness, as well as its public health impact, is en-
terohemorrhagic E. coli [15]. All 5 case patients showed the
typical picture of hemorrhagic colitis, including severe abdom-
inal pain and grossly bloody diarrhea. Some individuals de-
velop hemolytic uremic syndrome after the initial diarrheal
phase of illness [17], as was observed in 1 of the patients with
enterohemorrhagic E. coli infection. None of the isolates be-
longed to the E. coli serogroup O157, consistent with the rarity
of this strain in most European countries [9, 15]. The entero-
hemorrhagic E. coli prevalence in the present study is similar
to data obtained several years ago [10].
Despite attempts to identify many pathogens, no pathogen
was isolated in ∼50% of cases. Several viral pathogens like
Astrovirus or other enteric viruses [18, 19] as well as parasites,
were not looked for.
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Figure 1. MRI from the brain of a 25-month-old patient with sub-
acute sclerosing panencephalitis, showing increased signal intensity of
the complete right hemisphere and the left frontal lobe.
Rapid Progressive Subacute Sclerosing
Panencephalitis in a 2-Year-Old Child
with Congenital Athyreosis
We present the unique case of a 2-year-old girl with
congenital athyreosis who acquired primary measles virus
infection at the age of 18 months, coincidentally with an
Epstein-Barr virus infection. First neurologic symptoms
of subacute sclerosing panencephalitis appeared 5 months
later, and the girl died within 6 months after a rapid pro-
gressive illness. Factors possibly predisposing to this
extraordinary disease course—primary measles virus in-
fection at an early age and lack of evidence for immuno-
deficiency—are discussed.
Subacute sclerosing panencephalitis (SSPE) is a rare subacute
infection of the CNS caused by measles virus (MV) [1]. The
invariably fatal disease occurs several years after primary MV
infection [2] and is characterized by uncontrolled replication of
mutated and defective MV in neuronal and glial cells [3]. MV
infection that occurs before 2 years of age is associated with a
risk for SSPE that is 16 times as high as the risk associated with
infection after 5 years of age [4]. SSPE that occurs before 2 years
of age is extremely rare; we only found 2 cases in the literature
[5, 6]. Although the characteristic course of the disease is slowly
progressive, rare fulminating cases also have been reported [6,
7]. Most of these children had primary MV infection at an early
age or coincidentally with a second viral infection. We report on
Reprints or correspondence: Gerd M. Lackmann, Zentrum fu¨r Kinder-
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the case of a 2-year-old girl with congenital athyreosis who suf-
fered primary MV infection coincidentally with an Epstein-Barr
virus (EBV) infection at 18 months of age and who developed
fulminating SSPE 5 months later.
